Zhou, Xin https://orcid.org/0000-0001-9281-3612
Wang, Ying
Dou, Zhangqi
Delfanti, Gloria https://orcid.org/0000-0002-3935-1057
Tsahouridis, Ourania https://orcid.org/0000-0003-0621-6753
Pellegry, Caroline Marnata
Zingarelli, Manuela
Atassi, Gatphan https://orcid.org/0000-0003-3694-2123
Woodcock, Mark G. https://orcid.org/0000-0001-7348-4980
Casorati, Giulia https://orcid.org/0000-0002-5102-4112
Dellabona, Paolo https://orcid.org/0000-0002-1414-633X
Kim, William Y. https://orcid.org/0000-0001-7922-2156
Guo, Linjie
Savoldo, Barbara
Tsagaratou, Ageliki
Milner, J. Justin
Metelitsa, Leonid S. https://orcid.org/0000-0002-9639-6630
Dotti, Gianpietro https://orcid.org/0000-0002-2639-8526
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (R01-CA243543)
Division of Cancer Prevention, National Cancer Institute (R01-CA262250)
Associazione Italiana per la Ricerca sul Cancro (IG2017-ID.20081)
Associazione Italiana per la Ricerca sul Cancro (2019-ID.22737)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35-GM138289)
Article History
Received: 31 May 2023
Accepted: 28 August 2024
First Online: 1 October 2024
Competing interests
: G. Dotti serves in the SAB of Bellicum Pharmaceutical s.p.a., Catamaran Bio, Estella and Ouspecebio. The other authors declare no competing interests.